MedTrace Logo

Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil Regimens

NCT02063412 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2017-02-02

No results posted yet for this study

Summary

The objective of this study is to compare the possible time savings from reduction of nursing and pharmacy time to manage AEGC patients using capecitabine-based regimens versus traditional intravenous chemotherapy in the Hong Kong public hospital setting.

Conditions

Sponsors & Collaborators

  • Hoffmann-La Roche

    collaborator INDUSTRY

  • Queen Elizabeth Hospital, Hong Kong

    collaborator OTHER

  • Princess Margaret Hospital, Hong Kong

    collaborator OTHER_GOV

  • Vivian Wing Yan Lee

    lead OTHER

Principal Investigators

  • Vivian WY Lee, PharmD · Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-04-30
Completion
2014-04-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02063412 on ClinicalTrials.gov